Moreau F - Search Results

1

Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.

Morales R, Perrier S, Florent JM, Beltra J, Dufour S, De Mendez I, Manceau P, Tertre A, Moreau F, Compere D, Dublanchet AC, O'Gara M. Morales R, et al. Among authors: moreau f. J Mol Biol. 2004 Aug 20;341(4):1063-76. doi: 10.1016/j.jmb.2004.06.039. J Mol Biol. 2004. PMID: 15289103

2

Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.

Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A. Dublanchet AC, et al. Among authors: moreau f. Bioorg Med Chem Lett. 2005 Aug 15;15(16):3787-90. doi: 10.1016/j.bmcl.2005.05.079. Bioorg Med Chem Lett. 2005. PMID: 16002291

3

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies.

Vergne F, Bernardelli P, Lorthiois E, Pham N, Proust E, Oliveira C, Mafroud AK, Royer F, Wrigglesworth R, Schellhaas J, Barvian M, Moreau F, Idrissi M, Tertre A, Bertin B, Coupe M, Berna P, Soulard P. Vergne F, et al. Among authors: moreau f. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4607-13. doi: 10.1016/j.bmcl.2004.07.008. Bioorg Med Chem Lett. 2004. PMID: 15324874

4

Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: metabolism-directed optimization studies towards orally bioavailable derivatives.

Vergne F, Bernardelli P, Lorthiois E, Pham N, Proust E, Oliveira C, Mafroud AK, Ducrot P, Wrigglesworth R, Berlioz-Seux F, Coleon F, Chevalier E, Moreau F, Idrissi M, Tertre A, Descours A, Berna P, Li M. Vergne F, et al. Among authors: moreau f. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4615-21. doi: 10.1016/j.bmcl.2004.07.009. Bioorg Med Chem Lett. 2004. PMID: 15324875

5

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1.

Lorthiois E, Bernardelli P, Vergne F, Oliveira C, Mafroud AK, Proust E, Heuze L, Moreau F, Idrissi M, Tertre A, Bertin B, Coupe M, Wrigglesworth R, Descours A, Soulard P, Berna P. Lorthiois E, et al. Among authors: moreau f. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4623-6. doi: 10.1016/j.bmcl.2004.07.011. Bioorg Med Chem Lett. 2004. PMID: 15324876

6

Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 2: Optimization of 5,8-disubstituted derivatives.

Bernardelli P, Lorthiois E, Vergne F, Oliveira C, Mafroud AK, Proust E, Pham N, Ducrot P, Moreau F, Idrissi M, Tertre A, Bertin B, Coupe M, Chevalier E, Descours A, Berlioz-Seux F, Berna P, Li M. Bernardelli P, et al. Among authors: moreau f. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4627-31. doi: 10.1016/j.bmcl.2004.07.010. Bioorg Med Chem Lett. 2004. PMID: 15324877

7

Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose.

Grizot S, Salem M, Vongsouthi V, Durand L, Moreau F, Dohi H, Vincent S, Escaich S, Ducruix A. Grizot S, et al. Among authors: moreau f. J Mol Biol. 2006 Oct 20;363(2):383-94. doi: 10.1016/j.jmb.2006.07.057. Epub 2006 Jul 29. J Mol Biol. 2006. PMID: 16963083

8

New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors.

Devillers I, Pevet I, Jacobelli H, Durand C, Fasquelle V, Puaud J, Gaudillière B, Idrissi M, Moreau F, Wrigglesworth R. Devillers I, et al. Among authors: moreau f. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3303-6. doi: 10.1016/j.bmcl.2004.03.067. Bioorg Med Chem Lett. 2004. PMID: 15149695 No abstract available.

9

Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.

Moreau F, Desroy N, Genevard JM, Vongsouthi V, Gerusz V, Le Fralliec G, Oliveira C, Floquet S, Denis A, Escaich S, Wolf K, Busemann M, Aschenbrenner A. Moreau F, et al. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4022-6. doi: 10.1016/j.bmcl.2008.05.117. Epub 2008 Jun 5. Bioorg Med Chem Lett. 2008. PMID: 18571407

10

Relationship between phosphodiesterase type 4 inhibition and anti-inflammatory activity of CI-1044 in rat airways.

Pruniaux MP, Lagente V, Ouaged M, Bertin B, Moreau F, Julien-Larose C, Rocher MN, Leportier C, Martin B, Bouget A, Dubuit JP, Burnouf C, Doherty AM, Bertrand CP. Pruniaux MP, et al. Among authors: moreau f. Fundam Clin Pharmacol. 2010 Feb;24(1):73-82. doi: 10.1111/j.1472-8206.2009.00725.x. Epub 2009 Jul 24. Fundam Clin Pharmacol. 2010. PMID: 19650853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters